Clinical pharmacology of the reversal of neuromuscular block.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D004491:Edrophonium / Q000494:pharmacology; D005260:Female; D006024:Glycopyrrolate / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors*; D010197:Pancuronium / Q000037:antagonists & inhibitors; D011413:Propantheline / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D011729:Pyridostigmine Bromide / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D012602:Scopolamine Derivatives / Q000494:pharmacology; D013997:Time Factors
D009466:Neuromuscular Blocking Agents; D012602:Scopolamine Derivatives; D011413:Propantheline; D009388:Neostigmine; D004491:Edrophonium; D001285:Atropine; D010197:Pancuronium; D011729:Pyridostigmine Bromide; D006024:Glycopyrrolate